Editas Medicine - Stock Price History | EDIT

Historical daily share price chart and data for Editas Medicine since 2021 adjusted for splits. The latest closing stock price for Editas Medicine as of October 22, 2021 is 37.82.
  • The all-time high Editas Medicine stock closing price was 90.58 on January 08, 2021.
  • The Editas Medicine 52-week high stock price is 99.95, which is 164.3% above the current share price.
  • The Editas Medicine 52-week low stock price is 27.12, which is 28.3% below the current share price.
  • The average Editas Medicine stock price for the last 52 weeks is 47.86.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Editas Medicine Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 31.3180 29.4400 84.3500 14.8800 70.1100 136.78%
2019 24.0799 23.3400 32.6300 19.4300 29.6100 30.15%
2018 32.6293 34.3200 44.0800 18.1900 22.7500 -25.97%
2017 20.7403 17.0400 31.3400 13.6600 30.7300 89.34%
2016 23.7126 18.2000 42.0400 12.4600 16.2300 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.582B $0.091B
Editas Medicine, Inc. is a genome editing company. It focuses on translating its genome editing technology into a novel class of human therapeutics which enable precise and corrective molecular modification to treat diseases. Editas Medicine, Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76